NCT ID | NCT03471663 |
Title | A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer |
Recruitment | Recruiting |
Gender | female |
Phase | Phase I |
Variant Requirements | yes |
Sponsors | InventisBio Inc. |
Indications | |
Therapies | |
Age Groups: | adult senior |